Arrhythmia clinical trials

Explore recruiting arrhythmia clinical trials.

Recruiting arrhythmia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Arrhythmia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A first-in-human study to learn about how safe the study drug is in healthy participants

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

BLOCKADE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN PATIENTS WITH ARVD: A DOUBLE-BLIND MULTICENTRE PROSPECTIVE RANDOMIZED STUDY BRAVE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

AFLOAT - Assessment of flecainide to lower the patent formamen Ovale closure risk of Atrial arrhytmia or tachycardia

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE 2A, INVESTIGATOR AND SUBJECT BLINDED, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A controlled, randomized, first-in-human study of AP31969 investigating single and multiple ascending doses and the effect of food in healthy subjects

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Randomized, placebo-controlled, Phase III Study of (Neo)Adjuvant Atorvastatin Therapy in Patients with Early Breast Cancer

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Arrhythmia trials by city

Arrhythmia in Toronto Arrhythmia in Vancouver Arrhythmia in Montreal Arrhythmia in Calgary Arrhythmia in Edmonton Arrhythmia in Ottawa Arrhythmia in Winnipeg Arrhythmia in Quebec City Arrhythmia in Hamilton Arrhythmia in Kitchener Arrhythmia in London Arrhythmia in Halifax Arrhythmia in New York Arrhythmia in Los Angeles Arrhythmia in Chicago Arrhythmia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease